Gene therapy for hemophilia B by novel serotypes of AAV vectors

被引：0
作者：
Wang, LL
Gao, GP
Bell, P
Sanmiguel, J
Li, Y
Nichols, TC
Verma, IM
Wilson, JM
机构：
[1] Univ Penn, Sch Med, Philadelphia, PA 19104 USA
[2] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA
[3] Univ N Carolina, Chapel Hill, NC USA
[4] Salk Inst Biol Studies, La Jolla, CA USA
来源：
MOLECULAR THERAPY | 2003年 / 7卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
66
引用
收藏
页码：S26 / S26
页数：1
相关论文
共 50 条
  • [31] Evaluating AAV vectors for HHT gene therapy
    Liang, R.
    Press, K.
    Gonzalez, T.
    Asokan, A.
    Su, H.
    ANGIOGENESIS, 2023, 26 (01) : S4 - S4
  • [32] Gene therapy of feline gangliosidosis with AAV vectors
    Martin, Douglas R.
    Baker, Henry J.
    Cox, Nancy R.
    Cachon-Gonzalez, Begona
    Cox, Timothy M.
    MOLECULAR GENETICS AND METABOLISM, 2007, 92 (04) : S14 - S14
  • [33] Ultramicroscopy as a novel tool to unravel the tropism of AAV gene therapy vectors in the brain
    Alves, Sandro
    Bode, Julia
    Bemelmans, Alexis-Pierre
    von Kalle, Christof
    Cartier, Nathalie
    Tews, Bjoern
    SCIENTIFIC REPORTS, 2016, 6
  • [34] Efficient gene transduction in pigs and macaques with the engineered AAV vector AAV.GT5 for hemophilia B gene therapy
    Kashiwakura, Yuji
    Endo, Kazuhiro
    Ugajin, Atsushi
    Kikuchi, Tomohiro
    Hishikawa, Shuji
    Nakamura, Hitoyasu
    Katakai, Yuko
    Baatartsogt, Nemekhbayar
    Hiramoto, Takafumi
    Hayakawa, Morisada
    Kamoshita, Nobuhiko
    Yamazaki, Shoji
    Kume, Akihiro
    Mori, Harushi
    Sata, Naohiro
    Sakata, Yoichi
    Muramatsu, Shin-ichi
    Ohmori, Tsukasa
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2023, 30 : 502 - 514
  • [35] Hemophilia Healing with AAV: Navigating the Frontier of Gene Therapy
    Khan, Safir Ullah
    Khan, Munir Ullah
    Suleman, Muhammad
    Inam, Amrah
    Din, Muhammad Azhar Ud
    CURRENT GENE THERAPY, 2024, 24 (04) : 265 - 277
  • [36] Ultramicroscopy as a novel tool to unravel the tropism of AAV gene therapy vectors in the brain
    Sandro Alves
    Julia Bode
    Alexis-Pierre Bemelmans
    Christof von Kalle
    Nathalie Cartier
    Björn Tews
    Scientific Reports, 6
  • [37] Development of a Clinical Candidate AAV3 Vector for Gene Therapy of Hemophilia B
    Brown, Harrison C.
    Doering, Christopher B.
    Herzog, Roland W.
    Ling, Chen
    Markusic, David M.
    Spencer, H. Trent
    Srivastava, Alok
    Srivastava, Arun
    HUMAN GENE THERAPY, 2020, 31 (19-20) : 1114 - 1123
  • [38] Comparison of the efficacy on gene transfer by AAV vectors delivered by distinct routes of administration to the liver of hemophilia B dogs
    Arruda, V
    Scallan, A
    Jiang, HY
    Couto, L
    Herzog, RW
    Nichols, T
    Pierce, G
    High, KA
    MOLECULAR THERAPY, 2004, 9 : S40 - S41
  • [39] Gene transfer into skeletal muscle using novel AAV serotypes
    Louboutin, JP
    Wang, LL
    Wilson, JM
    JOURNAL OF GENE MEDICINE, 2005, 7 (04) : 442 - 451
  • [40] Comparison of AAV serotypes 2 and 5 based vectors for corrective gene therapy for late infantile neuronal ceroid lipofuscinosis
    Giannaris, EL
    De, BP
    Grant, A
    Lam, M
    Peterson, DA
    Sanders, CT
    Hackett, NR
    Sondhi, D
    Kaminsky, SM
    Crystal, RG
    MOLECULAR THERAPY, 2003, 7 (05) : S89 - S89
12345